Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 8/2014

01-08-2014 | Letter

Oral vancomycin might be useful to suppress enteral VRE load: a conceptual experiment

Authors: Joffrey van Prehn, Annette M. Stemerding, Hendrick K. F. Van Saene, Peter E. Spronk

Published in: Intensive Care Medicine | Issue 8/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM (1999) Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 29:361–366PubMedCrossRef
2.
Mondy KE, Shannon W, Mundy LM (2001) Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 33:473–476PubMedCrossRef
3.
Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R (1996) Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 173:1129–1136PubMedCrossRef
4.
Salgado CD, Giannetta ET, Farr BM (2014) Failure to develop vancomycin-resistant enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol 25:413–417CrossRef
5.
Al-Nassir WN, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ (2008) Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 52:2403–2406PubMedCentralPubMedCrossRef
Metadata
Title
Oral vancomycin might be useful to suppress enteral VRE load: a conceptual experiment
Authors
Joffrey van Prehn
Annette M. Stemerding
Hendrick K. F. Van Saene
Peter E. Spronk
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 8/2014
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3365-x

Other articles of this Issue 8/2014

Intensive Care Medicine 8/2014 Go to the issue

Correspondence

Untangling ICU delirium: is establishing its prevention in high-risk patients the final frontier?

What's New in Intensive Care

What is new in infection prevention in critical care in 2014?

Original

Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients

Understanding the Disease

Ten diseases you need to know if you want to be a critical care specialist in Hong Kong

Original

Behavioral changes in brain-injured critical care adults with different levels of consciousness during nociceptive stimulation: an observational study

Original

Distinct determinants of long-term and short-term survival in critical illness